[Leu15]-GastrinI(human) cas: 39024-57-2

[Leu15]-GastrinI(human) is a synthetic peptide that mimics the natural hormone gastrin produced in the stomach. Its full chemical name is Leucine-15-Gastrin I (human), and its molecular formula is C134H204N40O34S. It has a molecular weight of 2998.7 g/mol and is also known by its CAS number 39024-57-2.

This peptide is commonly used in research as it is involved in numerous physiological processes, including the regulation of acid secretion in the stomach, the stimulation of gastric growth and proliferation, and the modulation of intestinal motility. In this article, we will explore the top ten keywords associated with [Leu15]-GastrinI(human), its health benefits, potential effects, product mechanism, safety, side effects, and dosing information.

Top Ten Keywords and Synonyms

1. Gastrin hormone
2. Synthetic gastrin
3. Gastrointestinal peptides
4. Peptide mimetic
5. Digestive system
6. Acid secretion
7. Gastric cancer
8. Intestinal motility
9. Peptide therapy
10. Hormone replacement therapy

Health Benefits of [Leu15]-GastrinI(human)

Research has shown that [Leu15]-GastrinI(human) may have several potential health benefits. One of the primary benefits of this peptide is its ability to stimulate gastric acid secretion, which can improve digestion and prevent gastrointestinal disorders such as acid reflux and ulcers. Additionally, [Leu15]-GastrinI(human) has been found to stimulate the growth and proliferation of gastric cells, which may aid in the healing of damaged tissues.

Studies have also suggested that [Leu15]-GastrinI(human) may play a role in regulating intestinal motility, which can help alleviate symptoms of constipation and other digestive issues. Furthermore, this peptide has been investigated for its potential anticancer properties, particularly in the treatment of gastric cancer.

Potential Effects of [Leu15]-GastrinI(human)

The potential effects of [Leu15]-GastrinI(human) are wide-ranging and depend on the specific physiological process being targeted. Studies have suggested that this peptide may have the following effects:

1. Stimulate gastric acid secretion: [Leu15]-GastrinI(human) has been found to increase the production of gastric acid, which can aid in digestion and prevent gastrointestinal disorders.

2. Promote gastric cell growth and proliferation: Research has shown that [Leu15]-GastrinI(human) can stimulate the growth and proliferation of gastric cells, which may aid in the healing of damaged tissues and promote overall gastric health.

3. Regulate intestinal motility: This peptide may also play a role in regulating intestinal motility, which can alleviate symptoms of constipation and other digestive issues.

4. Anticancer properties: [Leu15]-GastrinI(human) has been investigated for its potential anticancer properties, particularly in the treatment of gastric cancer.

Product Mechanism

[Leu15]-GastrinI(human) works by binding to the cholecystokinin-B receptor (CCKBR) in the gastrointestinal tract. This receptor is responsible for regulating a variety of physiological processes, including gastric acid secretion, gastric cell growth, and intestinal motility. When [Leu15]-GastrinI(human) binds to the CCKBR, it stimulates these processes, leading to the potential health benefits discussed above.

Safety

Currently, there is limited information available regarding the safety of [Leu15]-GastrinI(human) in humans. However, studies conducted in animals have not revealed any significant adverse effects associated with its use. As with any new therapeutic agent, further research is needed to fully understand its safety profile in humans.

Side Effects

There have been no reported side effects associated with [Leu15]-GastrinI(human) in animal studies. However, due to the lack of human data, it is unclear whether this peptide may cause any adverse effects in humans.

Dosing Information

The optimal dose of [Leu15]-GastrinI(human) has not been established. However, animal studies suggest that doses ranging from 0.1 to 10 µg/kg may be effective in stimulating gastric acid secretion and promoting gastric cell growth.

Conclusion

Overall, [Leu15]-GastrinI(human) is a synthetic peptide that mimics the natural hormone gastrin produced in the stomach. While it is primarily used in research, it has shown potential as a therapeutic agent for a variety of gastrointestinal disorders, including acid reflux, ulcers, and constipation. Additionally, [Leu15]-GastrinI(human) has been investigated for its